Mizuho Securities analyst Uy Ear has maintained their neutral stance on RVNC stock, giving a Hold rating on November 11. Uy Ear’s rating ...

Werewolf Therapeutics ( (HOWL) ) just unveiled an update. Werewolf Therapeutics is pioneering the development of innovative cytokine therapies ...

JBI-802 is a first-in-class, orally administered, inhibitor of CoREST complex JBI-778 is a potential best-in-class, orally administered, brain penetrant inhibitor of PRMT5 MORRISVILLE, N.C., Oct. 25, ...

Viking Therapeutics (NASDAQ:VKTX) added ~18% on Thursday to reach a five-month high as Wall Street focused on updates on its obesity candidate VK2735, even as the company posted better-than ...

Toll-like receptors (TLRs) and their signalling pathways have therapeutic potential for the treatment of inflammation, cancer, infection, allergy and autoimmunity. The elucidation of the structure ...

RESEARCH TRIANGLE PARK, N.C, Oct. 22, 2024 /PRNewswire/ -- Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, has been selected as a participating ...

MONTREAL, Oct. 21, 2024 /CNW/ - Find Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced ...

Let’s honor that history and validate that in the balance, the principle of fundamental fairness requires that respect for the will and voice of the voter must prevail. Norman Eisen is a retired U.S.

Its enemies have been reduced to a motley assortment of homicidal maniacs, specializing in the murder of innocents and scrambling about in the bowels of the earth like rats You can save this ...